IL-23 and IL-17: function, disease and therapy

Similar documents
Chapter 43: The Immune System

The Most Common Autoimmune Disease: Rheumatoid Arthritis. Bonita S. Libman, M.D.

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

Autoimmunity and immunemediated. FOCiS. Lecture outline

2) Macrophages function to engulf and present antigen to other immune cells.

Name (print) Name (signature) Period. (Total 30 points)

Immune Checkpoint Blockade in Acute Myeloid Leukemia. Kinsey McCormick Hematology Fellow s Conference January 10, 2014

Rheumatoid arthritis: an overview. Christine Pham MD

A Genetic Analysis of Rheumatoid Arthritis

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

Predictive Biomarkers for Tumor Immunotherapy: Are we ready for clinical implementation? Howard L. Kaufman Rush University

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

Cancer and the immune system: can we beat cancer at its own game?

Figure 14.2 Overview of Innate and Adaptive Immunity

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

Oncos Therapeutics: ONCOS THERAPEUTICS Personalized Cancer Immunotherapy. March Antti Vuolanto, COO and co-founder

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

A disease and antibody biology approach to antibody drug discovery

B Cells and Antibodies

Medical Therapies Limited EGM Presentation

Drug Development Services

Natalia Taborda Vanegas. Doc. Sci. Student Immunovirology Group Universidad de Antioquia

Biologic Treatments for Rheumatoid Arthritis

Microbiology AN INTRODUCTION EIGHTH EDITION

Core Topic 2. The immune system and how vaccines work

Give a NOD to diabetes:

Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D.

The Immunopathogenesis of Relapsing MS

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

The Immune System and Disease

Methods for Measuring Dose Escalation in TNF Antagonists for Rheumatoid Arthritis Patients Treated in Routine Clinical Practice

Dendritic Cells: A Basic Review *last updated May 2003

Autoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity

The Immune System: A Tutorial

BIOM Firestein, Winter Rheumatoid arthritis. Page 1

A Local Stability of Mathematical Models for Cancer Treatment by Using Gene Therapy

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

BioMmune Technologies Inc. Corporate Presentation 2015

Overview of the Cattle Immune System 1

Corporate Medical Policy

Stem cell treatments of rheumatoid. arthritis and the implications of. their use in treating the condition

Immunosuppressive drugs

BVIG/SBMI Meeting Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium

Immunology and immunotherapy in allergic disease

FINAL REPORT For Japan-Korea Joint Research Project AREA

A link between gut microbiota, mucosal immunity and autoimmune arthritis. Hsin-Jung Joyce Wu "Microbiota and man: the story about us

Immune modulation in rheumatology. Geoff McColl University of Melbourne/Australian Rheumatology Association

The Body s Defenses CHAPTER 24

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

CHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L & SC.912.L.14.6

MEDICAL BREAKTHROUGHS RESEARCH SUMMARY

Objectives: Immunity Gone Wrong: Autoimmune Diseases in Dental Hygiene Practice

Clinically Actionable Biomarkers in Rheumatoid Arthritis

Cytotoxic and Biotherapies Credentialing Programme Module 2

Chapter 18: Applications of Immunology

Hypersensitivity. TYPE I Hypersensitivity Classic allergy. Allergens. Characteristics of allergens. Allergens. Mediated by IgE attached to Mast cells.

Immuno-Oncology Therapies to Treat Lung Cancer

CCR Biology - Chapter 9 Practice Test - Summer 2012

Immunotherapy Concept Turned Reality

International Symposium on Malignant Mesothelioma curemeso.org

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

What You Need to Know About Lung Cancer Immunotherapy

Basic Overview of Preclinical Toxicology Animal Models

The Prospect of Stem Cell Therapy in Multiple Sclerosis. Multiple sclerosis is a multifocal inflammatory disease of the central

Additional file 1. Progress of phase II clinical trials of Panagen

ABOUT RHEUMATOID ARTHRITIS

Immunity. Humans have three types of immunity innate, adaptive, and passive: Innate Immunity

Single-celled microorganisms, which can live inside or outside the body. Some cause sickness, but others are harmless.

Presenter Disclosure: Renier J. Brentjens, MD, PhD. Nothing to disclose

Focus on CNS Drug Development Treating secondary progressive multiple sclerosis. Simon Wilkinson, CEO

Basics of Immunology

Chapter 16: Innate Immunity

This information can also be found in the Summit 2011 Program on page 8.

Why use passive immunity?

Focus on Preventing Disease. keeping an eye on a healthy bottom line. Cattle Industry

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

Welcome to Mini Med School at the Child & Family Research Institute

An Introduction To Immunotherapy And The Promise Of Tissue Phenomics

If you were diagnosed with cancer today, what would your chances of survival be?

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

Rheumatoid Arthritis

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Media Release. Basel, 11 June RA patients with enhanced response identified

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

Roche s RoACTEMRA improved rheumatoid arthritis signs and symptoms significantly more than adalimumab as single-agent therapy

Staph Protein A, Immune Complexes, Cryoglobulins, and the Treatment of Rheumatoid Arthritis:

Gene Silencing Oligos (GSOs) Third Generation Antisense

Recent Multiple Sclerosis (MS)

SINPE trial, Ann Surg Overall morbidity. Minor Major. Infectious Non infectious. Post-hoc analysis WL < %5 (n=379) WL between 5-10% (n=49)

biologics for the treatment of psoriasis

Vitamin D deficiency exacerbates ischemic cell loss and sensory motor dysfunction in an experimental stroke model

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

VPM 152. INFLAMMATION: Chemical Mediators

1 DNA Vaccines An Overview

Mouse IFN-gamma ELISpot Kit

Lymphomas after organ transplantation

The public health risk of influenza in pigs recent insights, key knowledge gaps

Transcription:

IL-23 and IL-17: function, disease and therapy Daniele Conte a.a. 2006/2007

IL-23/IL-17 axis in inflammation and infection Yoichiro Iwakura and Harumichi Ishigame, 2006, IL-23/IL-17 axis in inflammation, jci, 116

IL-23

Preferential action of IL-23 on Memory T Cells Frucht DM. IL-23: a cytokine that acts on memory T cells. Sci STKE 2002;2002:PE1. IL-23 promote cellular immune response

IL-23 in diseases: IL-23 in autoimmune inflammation IL-23 plays a central role in the establishment and maintenance of organ-specific inflammatory autoimmune diseases. IL-23p19 KO mice are resistant to EAE, CIA Cua, D.J., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744 748.

IL-23 in diseases: Pro-tumour activity of IL-23 Langowski, J. L. et al., IL-23 promotes tumour incidence and growth. Nature, 2006. 442: 461 465. IL-17, G.CSF, granulocytes and macrophages are decreased in IL-23 KO IL-12 and IL-23 antagonize each other in tumour surveillance

IL 17

Function of Th17 cells David C. Wraith, Anti-cytokine vaccines and immunotherapy of autoimmune diseases, Eur. J. Immunol. 2006. 36: 2844 2848

The IL-17 super family Pleiotropic activity of the IL 17-family Major function of IL-17A/F/E Major function is chemoattractant activity through the induction of cytokines and chemokines: IL-17A and IL-17F: neutrophili IL-17E : eosinophili IL-17A and IL-17F have role in airway hyper responsiveness and other pathological changes including metaplasia and airway remodeling Kawaguchi M et al., IL-17 cytokine family. J Allergy Clin Immunol 2004;114:1265-73

IL-17 synergize to other cytokines with IL-1 and TNF-α to drive expression of numerous infiammatory effector with IFN-γ to promote chemokine gene expression IL-17 is in the midst of a complex network that amplifies inflammation IL-17 play during adaptive or memory immune responses. IL-17 may be to trigger innate immune responses shortly after a second encounter with antigen, when the memory response is activated but when concentrations of antigen are still too low to trigger a full-scale innate immune response. Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:240-247

IL 17 in diseases: IL 17 in bone metabolism and arthritic process M I Koenders et al., Potential new target in arthritis therapy:interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis, Ann Rheum Dis 2006;65;29-33 Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:240-247

IL 17 in diseases: RA, CIA and EAE In RA IL-17 is upregulated in early disease IL-17 knockout mice are resistant to CIA Development of EAE is reduced in IL-17 knockout mice Lubberts, E., et al. 2005. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7: 29 37. Komiyama, Y. Et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566 573.

IL 17 in diseases: IL-17 in other diseases Possible pathogenic role in viral infections (tropic Herpes virus saimiri) Elevated levels in bacterial infections Important role in immune response in the lung Patera AC, et al. : Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002, 299:56-63.. Linden A, Adachi M: Neutrophilic airway inflammation and IL- 17. Allergy 2002, 57:769-775 Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:240-247

IL 17 in diseases: in tumorigenesis The role played by IL-17 in tumorigenesis is complex

IL 17 in diseases: in tumorigenesis IL-17 promote growth and tumorigenicity of human cervical tumors in nude mice Tartour E, et al.: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999, 59:3698-3704.

IL 17 in diseases: in tumorigenesis IL-17 inhibited the growth of hematopoietic tumors (mastocytoma P815 and lymphoma J558L in immunocompetent mice Benchetrit F, et al., Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell- dependent mechanism. Blood 2002, 99.

IL-17 in tumorigenesis: conclusion increased growth in nude mice IL-17 is pleiotropic a cytokine with opposite activities in the regulation of tumor growth Inhibition of immunogenic tumors in immunocompetent mice by T-cell-dependent mechanism Other cytokines have this feature These antagonistic activities of cytokines in the regulation of tumor growth, which often depends on the immunogenicity of the tumor model, must be taken into consideration when these molecules are used in trials of immunotherapy.

Immunotherapy of autoimmune diseases with Anti-cytokine vaccines

Autoimmune myocardits: IL17VLP vaccination IL-12 p35 KO and WT mice developed myocarditis p40 KO mice show low level of disease. Injection of anti-p19 antibody reduced the disease Sonderegger, I. et al., Neutralization of IL-17 by active vaccination inhibits IL-23-mediated autoimmune myocarditis. Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636484

Autoimmune arthritis: IL17-VLP vaccination CIA Rhn, T. A. et al., Vaccination against IL 17 suppresses autoimmune arthritis and encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636658

auto-immune encephalomyelitis IL17 chemically coupled to ovalbumin Uyttenhove, C. and Van Snick, J., Development of an anti-il 17A autovaccine that prevents experimental auto-immune encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636662

Conclusion Central role of IL-17 and 23 in certain organ specific inflammatory autoimmune diseases. Inhibition of IL-17 activity with anti-cytokine vaccines in mouse More extensive human studies to define the precise role of IL-17 IL-17 have displayed both pro- and anti-tumour activities. IL-12 and IL-23 antagonize each other in tumour surveillance. IL-17 was shown to enhance the cytotoxic T cell response to murine haematopoietic tumours It is difficult to predict the effect that IL-17 inhibition will have on the susceptibility of an individual to different types of cancer.

References Yoichiro Iwakura and Harumichi Ishigame, 2006, IL-23/IL-17 axis in inflammation, jci, 116 Frucht DM. IL-23: a cytokine that acts on memory T cells. Sci STKE 2002;2002:PE1. Lankford CS and Frucht DM. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003;73:49 56. Langowski, J. L. et al., IL-23 promotes tumour incidence and growth. Nature, 2006. 442: 461 465. Chia-Hui Lo et al., 2003. Antitumor and antimetastatic activity of IL-23. J. Immunol. 171:600 607. Jing-Sheng Hao and Bao-En Shan, 2006, Immune enhancement and anti-tumor activity of IL-23, Cancer Immunol Immunother, 55: 1426-143 David C. Wraith, Anti-cytokine vaccines and immunotherapy of autoimmune diseases, Eur. J. Immunol. 2006. 36: 2844 2848 Sarah L Gaffen, Biology of recently discovered cytokines: Interleukin-17 a unique inflammatory cytokine with roles in bone biology and arthritis, Arthritis Res Ther 2004, 6:240-247 Kawaguchi M et al., IL-17 cytokine family. J Allergy Clin Immunol 2004;114:1265-73 M I Koenders et al., Potential new target in arthritis therapy:interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis, Ann Rheum Dis 2006;65;29-3 Watford, W. T., et al. 2004. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202: 139 156. Lankford, C. S. R. and Frucht, D. M., A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 2003. 73: 49 56. Sonderegger, I. et al., Neutralization of IL-17 by active vaccination inhibits IL-23-mediated autoimmune myocarditis. Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636484 Rhn, T. A. et al., Vaccination against IL 17 suppresses autoimmune arthritis and encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636658 Uyttenhove, C. and Van Snick, J., Development of an anti-il 17A autovaccine that prevents experimental auto-immune encephalomyelitis Eur. J. Immunol. 2006. 36: DOI: 10.1002/eji.200636662 Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620-2627 (2003). Lubberts, E., M. I. Koenders, and W. B. van den Berg. 2005. The role of T cell interleukin-17 in conducting destructive arthritis: lessons from animal models. Arthritis Res. Ther. 7: 29 37.

Komiyama, Y. Et al., IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 2006. 177: 566 573. Tartour E, et al.: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999, 59:3698-3704. Benchetrit F, et al., Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell- dependent mechanism. Blood 2002, 99:2114-2121. Patera AC, et al. : Interleukin 17 modulates the immune response to vaccinia virus infection. Virology 2002, 299:56-63. Linden A, Adachi M: Neutrophilic airway inflammation and IL- 17. Allergy 2002, 57:769-775. Langrish, C. L. et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240 (2005). Cua, D.J., et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744 748.. Murphy, C.A., et al. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951 1957.

IL-23 promoting cellular immunity its production in hematopoietic cells is critical. its biological activity requires cell-specific expression Its important in indirectly control of infections IL-23 modulates DC costimulatory function pathways of IL-12 and IL-23 are very similar IL-23could act to down-regulate Stat4-dependent actions of IL-12 unique role for IL-23 in promoting cellular immune responses Watford, W. T., et al. 2004. Signaling by IL-12 and IL-23 and the immunoregulatory roles of STAT4. Immunol. Rev. 202: 139 156. Lankford, C. S. R. and Frucht, D. M., A unique role for IL-23 in promoting cellular immunity. J. Leukoc. Biol. 2003. 73: 49 56.

IL-17 promotes angiogenesis and tumor growth Numasaki, M. et al. Interleukin-17 promotes angiogenesis and tumor growth. Blood 101, 2620-2627 (2003).

IL-23 in diseases: IL-23 Promoting tumor incidence or anti-tumour activity? 27

Anti-tumour activity of IL-23 Chia-Hui Lo et al., 2003. Antitumor and antimetastatic activity of IL-23. J. Immunol. 171:600 607.